Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
Oligometastatic Non-Small Cell Lung Cancer (NSCLC) presents a unique opportunity for potential curative therapy. Improved cancer staging using PET/CT, MRI, and future cellular and molecular staging with circulating tumor cells and/or molecular markers will identify more patients with truly oligometa...
Saved in:
Main Authors: | Daniel R. Gomez, Yuzuru Niibe, Joe Y. Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Pulmonary Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/396592 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oligometastases/Oligo-Recurrence of Lung Cancer
by: Yuzuru Niibe, et al.
Published: (2013-01-01) -
Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
by: Wataru Takahashi, et al.
Published: (2012-01-01) -
The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary Diseases
by: Kazuhiro Usui, et al.
Published: (2011-01-01) -
Factors Affecting the Survival of Patients with Oligometastatic Non-Small-Cell Lung Cancer: A Meta-Analysis
by: Yu Shi, et al.
Published: (2019-01-01) -
Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog
by: Ting Ye, et al.
Published: (2019-03-01)